Special Issue "Novel Challenges and Therapeutic Options for Pulmonary Embolism and Deep Vein Thrombosis"
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Clinical Medicine, Cell, and Organism Physiology".
Deadline for manuscript submissions: 1 October 2023 | Viewed by 813
Special Issue Editors
Interests: pulmonary embolism; coronary artery disease; ACS; cardiogenic shock; left atrial appendage closure
Interests: pulmonary embolism; coronary artery disease; ACS; cardiogenic shock; intracoronary imaging; interventional cardiology
Special Issue Information
Dear Colleagues,
Venous thromboembolism, clinically presenting as deep vein thrombosis or pulmonary embolism, is the third most frequent acute cardiovascular syndrome.
In this clinical setting, the effects of partial or total occlusion of the pulmonary vascular bed could lead to very different clinical presentations and syndromes, ranging from cardiogenic shock needing hemodynamic support and reperfusion to respiratory failure and chronic pulmonary hypertension. One of the most challenging parts of venous thromboembolism management is the selection of the appropriate treatment according to the risk of the patient. Prediction of the recurrence of future events is still difficult in this scenario. In this regard, a comprehensive evaluation by a pulmonary embolism response team (PERT) is frequently needed to offer a personalized approach.
The aim of this issue is to evaluate the role of new options both medical or interventional for the treatment of pulmonary embolism or deep vein thrombosis as well as new tools for risk stratification such as machine learning or artificial intelligence.
Dr. Giacomo Boccuzzi
Dr. Luca Franchin
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pulmonary embolism
- deep vein thrombosis
- transcatheter thrombectomy
- risk stratification
- machine learning
- chronic thromboembolic pulmonary hypertension
